Insider Trading activities of Eli Lilly & Co (LLY)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eli Lilly & Co (LLY) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eli Lilly & Co since year 2005. Table 2 shows the detailed insider transactions of Eli Lilly & Co since 2005. The reporting company's ticker symbol is LLY. The reporting company's CIK number is 59478.
The total value of stock buying since 2005 is $5,197,032.
The total value of stock sales since 2005 is $3,175,961,807.
The total value of stock option exercises since 2005 is $40,933,407.


 1   2   3   4 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Eli Lilly & Co (LLY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-11 0 $0 405,000 $46,458,191 0 $0
2019-10 13,405 $1,452,052 190,000 $21,710,350 0 $0
2019-09 0 $0 243,452 $28,256,705 0 $0
2019-07 185 $20,066 0 $0 2,394 $0
2019-06 426 $50,280 16,000 $1,867,520 0 $0
2019-05 0 $0 7,577 $890,562 13,750 $0
2019-04 0 $0 16,535 $2,065,615 0 $0
2019-03 0 $0 431,847 $56,031,831 0 $0
2019-02 0 $0 625,000 $77,814,090 62,435 $0
2019-01 0 $0 194,000 $22,951,273 0 $0
2018-12 0 $0 40,500 $4,673,406 7,500 $0
2018-11 0 $0 975,000 $112,306,519 3,133 $0
2018-10 0 $0 402,000 $45,317,489 0 $0
2018-09 0 $0 576,600 $61,664,174 0 $0
2018-08 0 $0 1,150,000 $119,048,925 0 $0
2018-07 2,168 $206,436 930,000 $85,876,745 2,394 $0
2018-06 10,000 $862,200 525,000 $45,177,948 0 $0
2018-05 0 $0 362,453 $30,093,973 53,750 $0
2018-04 0 $0 202,544 $16,423,432 0 $0
2018-03 0 $0 3,860 $303,390 0 $0
2018-02 0 $0 11,401 $921,694 195,175 $0
2017-12 0 $0 252,617 $22,242,597 16,334 $0
2017-11 0 $0 2,003 $167,591 0 $0
2017-10 0 $0 205,000 $17,795,025 0 $0
2017-09 0 $0 385,000 $32,382,895 0 $0
2017-08 0 $0 180,000 $14,590,080 0 $0
2017-07 0 $0 220,000 $18,343,820 0 $0
2017-06 0 $0 449,733 $37,565,477 0 $0
2017-05 0 $0 25,000 $2,069,000 0 $0
2017-03 0 $0 210,000 $17,781,540 0 $0
2017-02 0 $0 478,162 $37,735,174 166,976 $0
2016-12 1,875 $135,805 223,335 $16,253,321 0 $0
2016-10 0 $0 2,248 $182,926 30,134 $0
2016-08 2,560 $205,875 0 $0 14,056 $0
2016-07 0 $0 881,213 $71,587,103 0 $0
2016-06 0 $0 435,992 $34,058,099 0 $0
2016-05 0 $0 390,000 $29,505,190 0 $0
2016-04 0 $0 380,000 $28,496,760 0 $0
2016-02 3,170 $249,225 34,583 $2,706,270 157,222 $0
2016-01 0 $0 5,000 $393,750 0 $0
2015-12 0 $0 655,000 $56,027,595 0 $0
2015-11 0 $0 205,000 $17,403,475 103,946 $5,839,684
2015-10 0 $0 675,000 $57,662,000 0 $0
2015-09 0 $0 250,000 $22,322,500 0 $0
2015-07 0 $0 25,000 $2,124,000 0 $0
2015-06 0 $0 630,000 $50,484,259 0 $0
2015-05 0 $0 805,200 $59,002,379 63,132 $3,442,818
2015-04 0 $0 0 $0 76,024 $4,271,028
2015-03 0 $0 374,000 $28,247,470 0 $0
2015-02 0 $0 156,470 $11,074,996 190,556 $507,642
2014-12 0 $0 370,000 $26,314,300 7,101 $395,170
2014-11 0 $0 400,750 $26,992,517 39,878 $2,224,133
2014-10 0 $0 590,126 $39,131,785 173,247 $8,614,860
2014-09 0 $0 615,000 $39,731,699 27,527 $1,532,656
2014-08 0 $0 0 $0 19,623 $1,094,239
2014-07 0 $0 527,065 $33,159,864 2,240 $0
2014-06 0 $0 865,000 $52,639,650 0 $0
2014-05 17,157 $1,015,093 630,000 $37,242,900 0 $0
2014-04 0 $0 350,000 $20,682,000 0 $0
2014-02 0 $0 19,648 $0 166,539 $0
2014-01 12,431 $0 0 $0 0 $0
2013-11 0 $0 0 $0 4,056 $0
2013-08 0 $0 5,000 $268,950 0 $0
2013-07 0 $0 12,500 $660,200 0 $0
2013-06 0 $0 5,000 $262,250 0 $0
2013-05 0 $0 15,000 $825,650 20,000 $0
2013-04 0 $0 8,500 $482,655 0 $0
2013-03 0 $0 24,000 $1,332,220 0 $0
2013-02 0 $0 37,646 $2,040,239 366,898 $0
2013-01 0 $0 15,000 $812,100 0 $0
2012-12 0 $0 0 $0 8,167 $0
2012-10 0 $0 10,000 $504,500 12,500 $0
2012-08 0 $0 5,000 $220,799 0 $0
2012-07 0 $0 5,000 $215,000 0 $0
2012-06 0 $0 7,125 $291,400 0 $0
2012-05 0 $0 8,295 $341,114 0 $0
2012-04 0 $0 2,000 $80,000 0 $0
2012-03 0 $0 2,000 $79,200 0 $0
2012-02 0 $0 29,284 $1,158,155 541,451 $0
2011-12 0 $0 5,787 $226,271 0 $0
2011-11 0 $0 10,700 $398,434 0 $0
2011-10 0 $0 5,700 $217,170 14,380 $0
2011-09 0 $0 5,700 $204,686 0 $0
2011-08 0 $0 5,700 $193,458 3,278 $0
2011-07 0 $0 10,700 $399,123 0 $0
2011-06 0 $0 15,700 $582,900 0 $0
2011-05 0 $0 9,078 $349,944 0 $0
2011-04 0 $0 17,700 $635,591 0 $0
2011-03 0 $0 16,000 $555,960 0 $0
2011-02 0 $0 74,170 $2,618,487 497,115 $0
2011-01 0 $0 3,100 $108,096 0 $0
2010-12 0 $0 3,100 $108,810 0 $0
2010-11 0 $0 3,100 $106,733 0 $0
2010-10 0 $0 3,100 $116,715 0 $0
2010-09 0 $0 3,100 $110,204 0 $0
2010-08 0 $0 3,100 $109,523 0 $0
2010-03 0 $0 8,811 $308,609 0 $0
2010-02 0 $0 10,200 $357,840 302,628 $0
2009-11 0 $0 2,673 $97,965 0 $0
2008-09 0 $0 512,000 $24,026,690 0 $0
2008-08 0 $0 2,228,908 $106,973,252 0 $0
2008-07 0 $0 513,900 $24,678,965 0 $0
2008-02 19,558 $1,000,000 29,822 $1,537,458 0 $0
2007-09 0 $0 720,033 $41,648,425 0 $0
2007-07 0 $0 249,400 $13,550,726 0 $0
2007-06 0 $0 129,533 $7,650,598 0 $0
2007-05 0 $0 2,602,859 $154,367,041 100,000 $5,479,999
2007-04 0 $0 1,187,954 $70,785,380 0 $0
2007-03 0 $0 7,289 $381,870 0 $0
2007-02 0 $0 17,382 $944,677 0 $0
2006-12 0 $0 153,700 $8,380,811 0 $0
2006-11 0 $0 1,433,200 $79,313,754 0 $0
2006-10 0 $0 576,750 $33,032,043 8,000 $276,760
2006-09 0 $0 539,950 $29,834,437 52,250 $1,807,587
2006-08 0 $0 2,466,500 $137,462,274 82,710 $2,861,352
2006-07 0 $0 572,000 $31,917,463 0 $0
2006-06 0 $0 815,000 $42,068,177 35,000 $1,210,825
2006-05 0 $0 3,425,800 $176,806,260 0 $0
2006-04 0 $0 321,800 $16,954,930 0 $0
2006-03 0 $0 1,617,800 $92,425,527 0 $0
2006-02 0 $0 27,370 $1,543,281 43,530 $1,374,654
2005-12 0 $0 5,000 $280,700 0 $0
2005-08 0 $0 3,710,300 $200,374,143 0 $0
2005-07 0 $0 521,500 $28,722,387 0 $0
2005-05 0 $0 861,800 $51,119,739 0 $0
2005-04 0 $0 642,200 $37,846,009 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Eli Lilly & Co insiders (LLY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-11-19 Lilly Endowment Inc (10% Owner) Sale 205,000 115.36 23,649,415
2019-11-18 Lilly Endowment Inc (10% Owner) Sale 10,598 114.00 1,208,172
2019-11-12 Lilly Endowment Inc (10% Owner) Sale 7,981 114.00 909,841
2019-11-11 Lilly Endowment Inc (10% Owner) Sale 100 114.06 11,406
2019-11-07 Lilly Endowment Inc (10% Owner) Sale 400 114.37 45,749
2019-11-06 Lilly Endowment Inc (10% Owner) Sale 173,918 114.05 19,835,000
2019-11-04 Lilly Endowment Inc (10% Owner) Sale 7,003 114.04 798,608
2019-10-31 Lilly Endowment Inc (10% Owner) Sale 190,000 114.27 21,710,350
2019-10-25 White Anne E. (SVP & Pres-Lilly Oncology) Buy 1,000 108.84 108,840
2019-10-25 Skovronsky Daniel (SVP, CSO, and Pres. LRL) Buy 5,000 108.61 543,050
2019-10-25 Smiley Joshua L (SVP and CFO) Buy 929 107.59 99,951
2019-10-25 Ricks David A (President & CEO) Buy 4,615 108.38 500,173
2019-10-24 Tai Jackson P Buy 1,861 107.49 200,038
2019-09-20 Zulueta Alfonso G (SVP & President, Lilly Int'l) Sale 4,500 117.00 526,500
2019-09-20 Lilly Endowment Inc (10% Owner) Sale 210,000 116.39 24,441,480
2019-09-05 Fry Stephen F (SVP, HR & Diversity) Sale 9,452 115.00 1,086,980
2019-09-03 Zulueta Alfonso G (SVP & President, Lilly Int'l) Sale 19,500 112.91 2,201,745
2019-07-15 Smiley Joshua L (SVP and CFO) Buy 185 108.47 20,066
2019-07-05 Pusey Leigh Ann (SVP, Corp. Affairs & Comm.) Option Ex 2,394 .00 0
2019-06-05 Smiley Joshua L (SVP and CFO) Buy 426 118.03 50,280
2019-06-03 Harrington Michael J (Senior VP and General Counsel) Sale 16,000 116.72 1,867,520
2019-05-03 Shaw Christi (SVP and Pres., Lilly Bio-Meds) Sale 7,577 117.53 890,562
2019-05-01 Shaw Christi (SVP and Pres., Lilly Bio-Meds) Option Ex 13,750 .00 0
2019-04-12 Zulueta Alfonso G (SVP & President, Lilly Int'l) Sale 10,000 124.65 1,246,500
2019-04-12 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Sale 4,735 125.15 592,585
2019-04-05 Shah Aarti S. (SVP & CIO) Sale 1,800 125.85 226,530
2019-03-26 Lilly Endowment Inc (10% Owner) Sale 205,000 131.71 26,999,935
2019-03-22 Zakrowski Donald A (Chief Accounting Officer) Sale 1,000 128.50 128,500
2019-03-12 Fry Stephen F (SVP, HR & Diversity) Sale 14,847 123.16 1,828,556
2019-03-01 Zakrowski Donald A (Chief Accounting Officer) Sale 1,000 127.01 127,010
2019-03-01 Lilly Endowment Inc (10% Owner) Sale 210,000 128.32 26,947,830
2019-02-28 Lilly Endowment Inc (10% Owner) Sale 200,000 127.02 25,403,400
2019-02-22 Lilly Endowment Inc (10% Owner) Sale 195,000 124.19 24,217,635
2019-02-19 Lilly Endowment Inc (10% Owner) Sale 205,000 122.77 25,168,055
2019-02-16 Norton Johna (Senior VP, Global Quality) Option Ex 48 .00 0
2019-02-15 Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) Sale 25,000 121.00 3,025,000
2019-02-01 O'neill Myles (SVP & Pres., Mfg. Operations) Option Ex 3,221 .00 0
2019-02-01 Zulueta Alfonso G (SVP & President, Lilly Int'l) Option Ex 9,722 .00 0
2019-02-01 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Option Ex 3,333 .00 0
2019-02-01 Harrington Michael J (Senior VP and General Counsel) Option Ex 12,778 .00 0
2019-02-01 Ricks David A (President & CEO) Option Ex 12,222 .00 0
2019-02-01 Fry Stephen F (SVP, HR & Diversity) Option Ex 8,889 .00 0
2019-02-01 Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) Option Ex 12,222 .00 0
2019-01-31 Zulueta Alfonso G (SVP & President, Lilly Int'l) Sale 4,000 120.00 480,000
2019-01-17 Lilly Endowment Inc (10% Owner) Sale 136,577 118.47 16,180,823
2019-01-16 Lilly Endowment Inc (10% Owner) Sale 1,657 117.87 195,315
2019-01-15 Lilly Endowment Inc (10% Owner) Sale 51,766 117.74 6,095,135
2018-12-10 O'neill Myles (SVP & Pres., Mfg. Operations) Sale 25,000 113.16 2,828,875
2018-12-04 Lilly Endowment Inc (10% Owner) Sale 15,500 119.00 1,844,531
2018-12-02 White Anne E. (SVP & Pres-Lilly Oncology) Option Ex 7,500 .00 0
2018-11-29 Lilly Endowment Inc (10% Owner) Sale 185,000 117.65 21,765,990
2018-11-28 Lilly Endowment Inc (10% Owner) Sale 190,000 115.57 21,957,920
2018-11-19 Lilly Endowment Inc (10% Owner) Sale 195,000 115.30 22,484,085
2018-11-16 Lilly Endowment Inc (10% Owner) Sale 200,000 113.73 22,747,000
2018-11-13 Lilly Endowment Inc (10% Owner) Sale 2,460 113.41 278,978
2018-11-12 Lilly Endowment Inc (10% Owner) Sale 202,540 113.92 23,072,546
2018-11-03 Norton Johna (Senior VP, Global Quality) Option Ex 3,133 .00 0
2018-10-17 Lilly Endowment Inc (10% Owner) Sale 174,696 113.25 19,783,623
2018-10-09 Lilly Endowment Inc (10% Owner) Sale 10,672 115.91 1,237,012
2018-10-08 Lilly Endowment Inc (10% Owner) Sale 14,632 115.91 1,696,039
2018-10-04 Zulueta Alfonso G (SVP & President, Lilly Int'l) Sale 7,000 114.64 802,480
2018-10-04 Lilly Endowment Inc (10% Owner) Sale 116,038 113.68 13,191,083
2018-10-03 Lilly Endowment Inc (10% Owner) Sale 78,962 109.00 8,607,252
2018-09-28 Lilly Endowment Inc (10% Owner) Sale 107,553 107.31 11,541,082
2018-09-27 Lilly Endowment Inc (10% Owner) Sale 92,447 107.00 9,891,644
2018-09-26 Lilly Endowment Inc (10% Owner) Sale 134,410 106.97 14,377,972
2018-09-25 Lilly Endowment Inc (10% Owner) Sale 55,590 106.41 5,915,165
2018-09-18 Zulueta Alfonso G (SVP & President, Lilly Int'l) Sale 3,000 107.00 321,000
2018-09-17 Zulueta Alfonso G (SVP & President, Lilly Int'l) Sale 3,000 105.61 316,830
2018-09-07 Lilly Endowment Inc (10% Owner) Sale 180,000 106.87 19,237,140
2018-09-04 Zakrowski Donald A (Chief Accounting Officer) Sale 600 105.57 63,341
2018-08-30 Lilly Endowment Inc (10% Owner) Sale 190,000 105.42 20,030,370
2018-08-20 Lilly Endowment Inc (10% Owner) Sale 195,000 105.89 20,647,575
2018-08-16 Lilly Endowment Inc (10% Owner) Sale 200,000 104.50 20,899,800
2018-08-15 Lilly Endowment Inc (10% Owner) Sale 151,793 103.23 15,669,439
2018-08-10 Lilly Endowment Inc (10% Owner) Sale 3,587 103.06 369,676
2018-08-07 Lilly Endowment Inc (10% Owner) Sale 24,620 103.22 2,541,325
2018-08-06 Lilly Endowment Inc (10% Owner) Sale 195,000 102.15 19,918,860
2018-08-02 Lilly Endowment Inc (10% Owner) Sale 190,000 99.85 18,971,880
2018-07-31 Lilly Endowment Inc (10% Owner) Sale 205,000 98.94 20,282,290
2018-07-26 Tai Jackson P Buy 2,168 95.22 206,436
2018-07-25 Lilly Endowment Inc (10% Owner) Sale 190,000 95.13 18,075,080
2018-07-24 Lilly Endowment Inc (10% Owner) Sale 185,000 92.19 17,055,335
2018-07-06 Lilly Endowment Inc (10% Owner) Sale 180,000 87.44 15,738,300
2018-07-05 Pusey Leigh Ann (SVP, Corp. Affairs & Comm.) Option Ex 2,394 .00 0
2018-07-05 Lilly Endowment Inc (10% Owner) Sale 170,000 86.62 14,725,740
2018-06-15 Lilly Endowment Inc (10% Owner) Sale 180,000 86.65 15,597,720
2018-06-14 Skovronsky Daniel (SVP, CSO, and Pres. LRL) Buy 10,000 86.22 862,200
2018-06-14 Lilly Endowment Inc (10% Owner) Sale 107,698 86.31 9,295,414
2018-06-13 Lilly Endowment Inc (10% Owner) Sale 11,104 86.27 957,953
2018-06-11 Lilly Endowment Inc (10% Owner) Sale 51,198 86.38 4,422,636
2018-06-04 Lilly Endowment Inc (10% Owner) Sale 135,478 85.12 11,532,564
2018-06-01 Lilly Endowment Inc (10% Owner) Sale 39,522 85.31 3,371,661
2018-05-31 Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) Sale 25,000 85.00 2,125,000
2018-05-30 Lilly Endowment Inc (10% Owner) Sale 180,000 83.85 15,092,640
2018-05-29 Shaw Christi (SVP and Pres., Lilly Bio-Meds) Sale 8,426 82.10 691,774
2018-05-11 Lilly Endowment Inc (10% Owner) Sale 140,000 81.97 11,475,940
2018-05-03 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Sale 9,027 78.50 708,619
2018-05-01 Shaw Christi (SVP and Pres., Lilly Bio-Meds) Option Ex 13,750 .00 0
2018-05-01 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Option Ex 20,000 .00 0
2018-05-01 Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) Option Ex 20,000 .00 0
2018-04-25 Lilly Endowment Inc (10% Owner) Sale 180,000 81.21 14,617,799
2018-04-16 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 17,379 80.08 1,391,710
2018-04-13 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 5,165 80.14 413,923
2018-03-16 Smiley Joshua L (SVP and CFO) Sale 3,000 79.20 237,600
2018-03-01 Zakrowski Donald A (Chief Accounting Officer) Sale 860 76.50 65,790
2018-02-21 Zakrowski Donald A (Chief Accounting Officer) Sale 876 77.55 67,933
2018-02-16 Norton Johna (Senior VP, Global Quality) Option Ex 48 .00 0
2018-02-05 Zakrowski Donald A (Chief Accounting Officer) Sale 900 81.09 72,981
2018-02-05 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Sale 9,625 81.12 780,780
2018-02-01 O'neill Myles (SVP & Pres., Mfg. Operations) Option Ex 9,596 .00 0
2018-02-01 Zulueta Alfonso G (SVP & President, Lilly Int'l) Option Ex 15,993 .00 0
2018-02-01 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Option Ex 6,398 .00 0
2018-02-01 Harrington Michael J (Senior VP and General Counsel) Option Ex 24,524 .00 0
2018-02-01 Ricks David A (President & CEO) Option Ex 21,326 .00 0
2018-02-01 Fry Stephen F (SVP, HR & Diversity) Option Ex 17,060 .00 0
2018-02-01 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Option Ex 36,252 .00 0
2018-02-01 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Option Ex 21,326 .00 0
2018-02-01 Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) Option Ex 21,326 .00 0
2018-02-01 Mahony Susan (SVP & Pres., Lilly Oncology) Option Ex 21,326 .00 0
2017-12-13 Lilly Endowment Inc (10% Owner) Sale 200,000 88.53 17,705,200
2017-12-11 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Sale 12,500 86.46 1,080,750
2017-12-04 Zulueta Alfonso G (SVP & President, Lilly Int'l) Sale 3,532 86.00 303,752
2017-12-04 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 36,585 86.18 3,152,895
2017-12-03 Zakrowski Donald A (Chief Accounting Officer) Option Ex 3,281 .00 0
2017-12-03 Ricks David A (President & CEO) Option Ex 5,496 .00 0
2017-12-03 Fry Stephen F (SVP, HR & Diversity) Option Ex 7,557 .00 0
2017-11-10 Zulueta Alfonso G (SVP & President, Lilly Int'l) Sale 2,003 83.67 167,591
2017-10-04 Lilly Endowment Inc (10% Owner) Sale 205,000 86.81 17,795,025
2017-09-29 Lilly Endowment Inc (10% Owner) Sale 195,000 85.28 16,630,185
2017-09-15 Lilly Endowment Inc (10% Owner) Sale 190,000 82.91 15,752,710
2017-08-31 Lilly Endowment Inc (10% Owner) Sale 180,000 81.06 14,590,080
2017-07-31 Lilly Endowment Inc (10% Owner) Sale 220,000 83.38 18,343,820
2017-06-22 Lilly Endowment Inc (10% Owner) Sale 210,000 84.43 17,730,720
2017-06-20 Lilly Endowment Inc (10% Owner) Sale 215,000 83.05 17,855,320
2017-06-12 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Sale 1,900 80.78 153,482
2017-06-09 Harrington Michael J (Senior VP and General Counsel) Sale 22,833 79.97 1,825,955
2017-05-04 Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) Sale 25,000 82.76 2,069,000
2017-03-30 Lilly Endowment Inc (10% Owner) Sale 210,000 84.67 17,781,540
2017-02-17 Lilly Endowment Inc (10% Owner) Sale 230,000 80.27 18,462,790
2017-02-06 Zulueta Alfonso G (SVP& Pres., Emerging Markets) Sale 15,000 77.66 1,164,900
2017-02-03 Rice Derica W (EVP-Global Services and CFO) Sale 3,892 77.47 301,513
2017-02-02 Zakrowski Donald A (Chief Accounting Officer) Sale 2,000 77.52 155,040
2017-02-02 Rice Derica W (EVP-Global Services and CFO) Sale 7,270 76.97 559,571
2017-02-01 Zulueta Alfonso G (SVP& Pres., Emerging Markets) Option Ex 6,659 .00 0
2017-02-01 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Option Ex 3,073 .00 0
2017-02-01 Harrington Michael J (Senior VP and General Counsel) Option Ex 9,732 .00 0
2017-02-01 Ricks David A (President & CEO) Option Ex 10,244 .00 0
2017-02-01 Crowe Maria A (President, Mfg. Operations) Option Ex 8,195 .00 0
2017-02-01 Walsh Fionnuala M (SVP, Global Quality) Option Ex 4,610 .00 0
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of LLY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eli Lilly & Co (symbol LLY, CIK number 59478) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month